Former buy-side analyst. Leads the desk with a focus on global markets, macro flows and what moves portfolios.

OpenAI has paused some work on its next model, Astra, after internal tests suggested it might be able to autonomously find and exploit serio

Tandem Diabetes Care's PayGo program is shifting how insulin pumps are paid for. RBC estimates 10% of US sales went through pharmacy channel

RBC Capital Markets says early prescription data for Cytokinetics' new heart drug Myqorzo shows a healthy launch, with rising scripts and ma

RBC Capital Markets raised its price target on Howmet Aerospace to $350 from $325, citing strong demand for engine parts and capacity expans

Europe's STOXX 600 notched a fourth straight record close, up 0.3% to 660.25, as tech stocks and upbeat earnings drove gains. Softer US payr

Gold miners led the FTSE 100 higher on Friday as bullion prices jumped, offsetting weakness in oil majors. The index rose 0.3% despite crude

Glencore's planned secondary listing in Australia could trigger significant buying from index funds if it joins the ASX 200. Berenberg notes

ResMed guided to fiscal 2027 revenue of $5.75-5.85 billion, factoring a $75 million hit from the Astral ventilator recall. Shares fell about

Doximity shares jumped after the digital health platform raised its fiscal 2027 revenue forecast and said its Doximity Ask AI model beat the

Apollo says redemption requests in its private credit fund have halved since the last tender, while Ares shrank a continuation fund after bu

July payrolls unexpectedly fell by 23,000 and wage growth cooled to 3.2% year-over-year, sending Treasury yields lower. Traders trimmed odds

US stock futures ticked up after July unemployment held at 4.1%, easing fears of a sharp slowdown. Investors also kept an eye on Strait of H